1,054
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Systolic murmur in disguise: subclavian artery stenosis as an overlooked cause of missed case of hypertension

, &
Pages 75-78 | Received 05 Aug 2020, Accepted 15 Aug 2020, Published online: 01 Sep 2020

References

  • Salman R, Hornsby J, Wright LJ, et al. Treatment of subclavian artery stenosis: a case series. Int J Surg Case Rep. 2016;19:69–74.
  • Saha T, Naqvi SY, Ayah OA, et al. Subclavian artery disease: diagnosis and therapy. Am J Med. 2017;130(4):409–416.
  • Aboyans V, Criqui MH, McDermott MM, et al. The vital prognosis of subclavian stenosis. J Am Coll Cardiol. 2007;49(14):1540–1545.
  • Stone PA, Srivastiva M, Campbell JE, et al. Diagnosis and treatment of subclavian artery occlusive disease. Expert Rev Cardiovasc Ther. 2010;8(9):1275–1282.
  • Clark CE, Taylor RS, Shore AC, et al. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet. 2012;379(9819):905–914.
  • Williams B, Mancia G, Spiering W, et al. Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Pressure. 2018;27(6):314–340.
  • Aboyans V, Ricco J-B, Bartelink M-L, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017;39(9):763–816.
  • Fowkes FG, Price JF, Stewart MC, et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA. 2010;303(9):841–848.
  • Mach F, Baigent C, Catapano AL, ESC Scientific Document Group, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020;41(1):111–188.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.